FRANKLIN STREET ADVISORS INC /NC - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN STREET ADVISORS INC /NC ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$31
-35.4%
105,8000.0%0.00%
-40.0%
Q4 2022$48
-99.9%
105,8000.0%0.01%
-16.7%
Q3 2022$56,000
+5.7%
105,8000.0%0.01%
+20.0%
Q2 2022$53,000
-78.2%
105,8000.0%0.01%
-75.0%
Q1 2022$243,000
-51.7%
105,8000.0%0.02%
-47.4%
Q4 2021$503,000
-39.0%
105,800
+2.1%
0.04%
-45.7%
Q3 2021$824,000
+14.3%
103,6000.0%0.07%
+14.8%
Q2 2021$721,000
-12.2%
103,6000.0%0.06%
-19.7%
Q1 2021$821,000
+42.0%
103,600
+41.0%
0.08%
+35.7%
Q4 2020$578,000
+10.9%
73,5000.0%0.06%0.0%
Q3 2020$521,000
+12.5%
73,500
+47.0%
0.06%
+1.8%
Q2 2020$463,000
+184.0%
50,000
+42.9%
0.06%
+129.2%
Q1 2020$163,000
-28.8%
35,000
+16.7%
0.02%
-11.1%
Q4 2019$229,000
-0.9%
30,0000.0%0.03%
-6.9%
Q3 2019$231,000
+12.1%
30,0000.0%0.03%
+7.4%
Q2 2019$206,000
-14.9%
30,0000.0%0.03%
-20.6%
Q1 2019$242,000
+61.3%
30,000
+50.0%
0.03%
+41.7%
Q4 2018$150,00020,0000.02%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 112,044$50,4200.68%
Aisling Capital Management LP 1,691,151$761,0180.50%
Sio Capital Management, LLC 3,004,959$1,351,9310.50%
Bain Capital Life Sciences Investors, LLC 5,347,689$2,4060.27%
Ghost Tree Capital, LLC 800,000$360,0000.15%
Nantahala Capital Management 4,611,302$2,074,6250.13%
Samsara BioCapital, LLC 883,720$397,5860.09%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$1,826,5460.08%
SPHERA FUNDS MANAGEMENT LTD. 440,837$198,3330.04%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1110.04%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders